本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Concert Pharmaceuticals, Inc.

8.37
0.0000
成交量:- -
成交额:9,016.00万
市值:5.21亿
市盈率:-2.69
高:8.37
开:8.37
低:8.37
收:8.37
数据加载中...
2023/03/06

交易所摘牌声明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2023/03/06

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/03/06

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/03/06

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/03/06

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/03/06

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/03/06

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/03/06

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/03/06

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/03/06

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/03/06

重要事件披露

8-K - Current report
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/01/19

重要事件披露

8-K - Current report
2022/11/07

重要事件披露

8-K - Current report
2022/11/07

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/22

重要事件披露

8-K - Current report